|
Volumn 366, Issue 5, 2012, Pages 474-476
|
Timing of antiretroviral therapy for HIV-1-associated tuberculosis [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFRICA SOUTH OF THE SAHARA;
ANTIRETROVIRAL THERAPY;
CD4 LYMPHOCYTE COUNT;
DRUG ADMINISTRATION;
DRUG THERAPY;
HEALTH CARE;
HIV 1 ASSOCIATED TUBERCULOSIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
LETTER;
OUTPATIENT DEPARTMENT;
PATIENT CARE;
PATIENT TRANSPORT;
PRIORITY JOURNAL;
SOUTH AFRICA;
TIME;
TUBERCULOSIS;
COMMUNITY PROGRAM;
FOLLOW UP;
HOSPITAL CARE;
HOSPITALIZATION;
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;
IMMUNOCOMPROMISED PATIENT;
OUTPATIENT CARE;
RISK REDUCTION;
AIDS RELATED COMPLEX;
FEMALE;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
NOTE;
ANTIRETROVIRUS AGENT;
TUBERCULOSTATIC AGENT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTI-RETROVIRAL AGENTS;
ANTITUBERCULAR AGENTS;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
TUBERCULOSIS;
|
EID: 84856562682
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1113986 Document Type: Letter |
Times cited : (7)
|
References (5)
|